News
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced new data from its preclinical study of ZL-1503, the Company’s promising IL-13/IL-31R bispecific antibody, demonstrating its ability to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback